103 related articles for article (PubMed ID: 9635715)
1. Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma.
Maor MH; North LB; Cabanillas FF; Ames AL; Hess MA; Cox JD
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):647-50. PubMed ID: 9635715
[TBL] [Abstract][Full Text] [Related]
2. Radiation treatment planning techniques for lymphoma of the stomach.
Della Biancia C; Hunt M; Furhang E; Wu E; Yahalom J
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):745-51. PubMed ID: 15936555
[TBL] [Abstract][Full Text] [Related]
3. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
[TBL] [Abstract][Full Text] [Related]
4. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
Sugimoto M; Kajimura M; Shirai N; Furuta T; Kanaoka S; Ikuma M; Sato Y; Hishida A
Intern Med; 2006; 45(6):405-9. PubMed ID: 16617193
[TBL] [Abstract][Full Text] [Related]
5. Intensity Modulated Radiation Therapy for Early-Stage Primary Gastric Diffuse Large B-Cell Lymphoma: Dosimetric Analysis, Clinical Outcome, and Quality of Life.
Liu X; Fang H; Tian Y; Wang WH; Song YW; Wang SL; Liu YP; He XH; Dong M; Ren H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):712-20. PubMed ID: 27034178
[TBL] [Abstract][Full Text] [Related]
6. Enhanced renal toxicity of total body irradiation combined with radioimmunotherapy.
Röttinger EM; Bartkowiak D; Bunjes D; Wennauer R; Dohr D
Strahlenther Onkol; 2003 Oct; 179(10):702-7. PubMed ID: 14566479
[TBL] [Abstract][Full Text] [Related]
7. Role of radiotherapy in the treatment of lymphomas of the gastrointestinal tract.
Aleman BM; Haas RL; van der Maazen RW
Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):27-34. PubMed ID: 20206106
[TBL] [Abstract][Full Text] [Related]
8. A prospective analysis of efficacy and long-term outcome of radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma.
Okada H; Takemoto M; Kawahara Y; Nasu J; Takenaka R; Kawano S; Inoue M; Ichimura K; Tanaka T; Shinagawa K; Yoshino T; Yamamoto K
Digestion; 2012; 86(3):179-86. PubMed ID: 22907329
[TBL] [Abstract][Full Text] [Related]
9. Long-term observations of radiation-induced creatinine clearance reduction and renal parenchymal volume atrophy.
Inaba K; Okamoto H; Wakita A; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Murakami N; Ito Y; Igaki H; Uno T; Itami J
Radiother Oncol; 2016 Jul; 120(1):145-9. PubMed ID: 27372224
[TBL] [Abstract][Full Text] [Related]
10. [Radiotherapy of MALT-lymphoma of the stomach].
Székely J; Petrányi A; Glavák C; Schneider T; Rosta A; Esik O
Orv Hetil; 2002 Jul; 143(28):1683-9. PubMed ID: 12152534
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
[TBL] [Abstract][Full Text] [Related]
12. Proteinuria and renal insufficiency three years after treatment of gastric lymphoma.
Markowitz GS; Goldstein CS; D'Agati VD
Am J Kidney Dis; 1999 Sep; 34(3):588-93. PubMed ID: 10469874
[No Abstract] [Full Text] [Related]
13. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy.
Alpen B; Kuse R; Parwaresch R; Müller-Hermelink HK; Stolte M; Neubauer A
J Clin Oncol; 2004 Aug; 22(15):3039-45. PubMed ID: 15284253
[TBL] [Abstract][Full Text] [Related]
14. Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up.
Ruskoné-Fourmestraux A; Matysiak-Budnik T; Fabiani B; Cervera P; Brixi H; Le Malicot K; Nion-Larmurier I; Fléjou JF; Hennequin C; Quéro L;
Radiother Oncol; 2015 Oct; 117(1):178-82. PubMed ID: 26395311
[TBL] [Abstract][Full Text] [Related]
15. [Results of a retrospective study on radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma].
Ghorbal L; Hdiji A; Ben Salah H; Elloumi F; Frikha M; Elloumi M; Daoud J
Cancer Radiother; 2018 Dec; 22(8):763-766. PubMed ID: 30337049
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent.
Teckie S; Qi S; Lovie S; Navarrett S; Hsu M; Noy A; Portlock C; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):130-7. PubMed ID: 25863760
[TBL] [Abstract][Full Text] [Related]
17. Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer.
Welz S; Hehr T; Kollmannsberger C; Bokemeyer C; Belka C; Budach W
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1429-35. PubMed ID: 17692474
[TBL] [Abstract][Full Text] [Related]
18. [A clinicopathological analysis of gastric lymphoma].
Xue LY; Lü N; Li AD; Zou SM; Lin DM; He ZG; Xie YQ; Liu XY
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):332-6. PubMed ID: 16185499
[TBL] [Abstract][Full Text] [Related]
19. Low grade MALT lymphoma of the stomach: treatment outcome with radiotherapy alone.
Park HC; Park W; Hahn JS; Kim CB; Lee YC; Noh JK; Suh CO
Yonsei Med J; 2002 Oct; 43(5):601-6. PubMed ID: 12402372
[TBL] [Abstract][Full Text] [Related]
20. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
